These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 17172420)
1. Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme. Madhankumar AB; Slagle-Webb B; Mintz A; Sheehan JM; Connor JR Mol Cancer Ther; 2006 Dec; 5(12):3162-9. PubMed ID: 17172420 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of interleukin-13 receptor-targeted liposomal doxorubicin in the intracranial brain tumor model. Madhankumar AB; Slagle-Webb B; Wang X; Yang QX; Antonetti DA; Miller PA; Sheehan JM; Connor JR Mol Cancer Ther; 2009 Mar; 8(3):648-54. PubMed ID: 19276162 [TBL] [Abstract][Full Text] [Related]
3. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901 [TBL] [Abstract][Full Text] [Related]
4. Dual functionalized liposomes for efficient co-delivery of anti-cancer chemotherapeutics for the treatment of glioblastoma. Lakkadwala S; Dos Santos Rodrigues B; Sun C; Singh J J Control Release; 2019 Aug; 307():247-260. PubMed ID: 31252036 [TBL] [Abstract][Full Text] [Related]
5. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model. Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761 [TBL] [Abstract][Full Text] [Related]
6. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery. Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902 [TBL] [Abstract][Full Text] [Related]
7. Treating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasound. Yang FY; Teng MC; Lu M; Liang HF; Lee YR; Yen CC; Liang ML; Wong TT Int J Nanomedicine; 2012; 7():965-74. PubMed ID: 22393293 [TBL] [Abstract][Full Text] [Related]
8. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model. Lakkadwala S; Singh J Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346 [TBL] [Abstract][Full Text] [Related]
9. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related]
10. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy. Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Mamot C; Drummond DC; Noble CO; Kallab V; Guo Z; Hong K; Kirpotin DB; Park JW Cancer Res; 2005 Dec; 65(24):11631-8. PubMed ID: 16357174 [TBL] [Abstract][Full Text] [Related]
12. Tumor-penetrating peptide functionalization enhances the anti-glioblastoma effect of doxorubicin liposomes. Yang Y; Yan Z; Wei D; Zhong J; Liu L; Zhang L; Wang F; Wei X; Xie C; Lu W; He D Nanotechnology; 2013 Oct; 24(40):405101. PubMed ID: 24029287 [TBL] [Abstract][Full Text] [Related]
13. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration. Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297 [TBL] [Abstract][Full Text] [Related]
14. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma. Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513 [TBL] [Abstract][Full Text] [Related]
15. A stabilized peptide ligand for multifunctional glioma targeted drug delivery. Ying M; Shen Q; Zhan C; Wei X; Gao J; Xie C; Yao B; Lu W J Control Release; 2016 Dec; 243():86-98. PubMed ID: 27693752 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. Husain SR; Puri RK J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884 [TBL] [Abstract][Full Text] [Related]
17. Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy. Kawakami K; Kioi M; Liu Q; Kawakami M; Puri RK J Immunother; 2005; 28(3):193-202. PubMed ID: 15838375 [TBL] [Abstract][Full Text] [Related]
18. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528 [TBL] [Abstract][Full Text] [Related]
19. Liposomes targeted to MHC-restricted antigen improve drug delivery and antimelanoma response. Saeed M; Zalba S; Seynhaeve ALB; Debets R; Ten Hagen TLM Int J Nanomedicine; 2019; 14():2069-2089. PubMed ID: 30988609 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. Yang FY; Wang HE; Liu RS; Teng MC; Li JJ; Lu M; Wei MC; Wong TT PLoS One; 2012; 7(9):e45468. PubMed ID: 23029030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]